Positions

Research Overview

  • BK infections in kidney transplant patients
    Alternative immunosuppression regimens for rapid metabolizers
    Skin cancer in kidney transplant patients
  • Principal Investigator On

    Investigator On

  • A Trial of Transplanting Hepatitis C-Viremic Kidneys Into Hepatitis C-Negative Kidney Recipients (THINKER-NEXT) Cost-Reimbursement  awarded by University of Pennsylvania
  • A Trial of Transplanting Hepatitis C-viremic Kidneys into Hepatitis C-Negative Kidney Recipients (THINKER-NEXT) Fixed Rate  awarded by University of Pennsylvania
  • APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • APOL1 Long-term kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • Applying Precision MEdicine to Optimize Desensitization with NoveL BIOlogics or Cellular TheRApies in Highly SensiTized Kidney Transplant PatiEnts (AMELIORATE)  awarded by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients  awarded by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients - Equipment  awarded by Mount Sinai School of Medicine ^
  • Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts  awarded by University of California, San Francisco
  • Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts  awarded by University of California, San Francisco
  • Preserving Renal Function & Protective Immunity via Anti-LFA-1-Based CNI Avoidance  awarded by Emory University
  • Private Grant  awarded by CINKATE CORPORATION
  • Private Grant  awarded by ASTELLAS PHARMA US, INC.
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC.
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC.
  • Private Grant  awarded by CAREDX INC.
  • Private Grant  awarded by QUARK PHARMACEUTICALS, INC.
  • Private Grant  awarded by MALLINCKRODT, INC.
  • Private Grant  awarded by ASTELLAS PHARMA US, INC.
  • Private Grant  awarded by TRANSPLANT GENOMICS, INC.
  • Private Grant  awarded by ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC. - NEW
  • Private Grant  awarded by CSL BEHRING, LLC
  • Private Grant  awarded by CSL BEHRING, LLC
  • Private Grant  awarded by TRANSPLANT GENOMICS, INC.
  • Private Grant  awarded by NATERA, INC.
  • Private Grant  awarded by CSL BEHRING, LLC
  • Private Grant  awarded by MALLINCKRODT, INC.
  • Private Grant  awarded by CAREDX INC.
  • Private Grant  awarded by TRANSPLANT GENOMICS, INC.
  • Private Grant  awarded by Gilead Sciences ^
  • Using Microarrays to Assess Transplant Biopsies: The Future Standard of Care (INTERCOMEX: The INTERCOM Extension Study)  awarded by University of Alberta at Edmonton
  • Education And Training

  • Baylor College of Medicine, Residency
  • Baylor College of Medicine, Postdoctoral Fellowship
  • Vanderbilt University Medical Center, Postdoctoral Fellowship
  • Doctor of Medicine, University of Texas System : Medical Branch 2006
  • Full Name

  • Graham Towns